Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
Clinical trial NCT00902044 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00902044
- Sponsor
- Baylor College of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-11
- Primary completion
- 2019-12-06
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.